Altered newborn gender distribution in patients with low mid-trimester maternal serum human chorionic gonadotropin (MShCG)

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 6, Issue 2, 1997, Pages 111-114

  Santolaya Forgas, Joaquin ^a,b,c   Meyer, William J ^a   Burton, Barbara K ^b   Scommegna, Antonio ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b MICHAEL REESE HOSPITAL   (United States)

^c M/C 808 ^*  (United States)

Author keywords

Human chorionic gonadotropin; Neonatal gender

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GENDER; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SEX DETERMINATION; SEX DIFFERENCE; THIRD TRIMESTER PREGNANCY;

CHORIONIC GONADOTROPIN; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; REFERENCE VALUES; SEX RATIO;

EID: 0030910524     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.3109/14767059709161966     Document Type: Article

References (22)

1. Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Annu Rev Biochem 50:465-495, 1981.
2. Birken S, Chen Y, Gawinowicz MA, Agosto GM, et al.: Structure and significance of human luteinizing hormone-beta core fragment purified from human pituitary extracts.Endocrinology 133:985-989, 1993.
3. O'Connor JF, Birken S, Lubstbader JW, et al.: Recent advances in the chemistry and immunochemistry of human chorionic gonadotropin: impact on clinical measurements. Endocr Rev 15:650-683, 1994.
4. Cunningham FG, MacDonald PC, Gant NF, Leveno K, Gilstrap LC, eds.: The placental hormones. In "Williams Obstetrics," 19th ed. Norwalk, CT: Appleton Lange, 139-164, 1993.
5. Speroff L, Glass RH, Kase NG, eds.: The endocrinology of pregnancy. In "Clinical Gynecologic Endocrinology and Infertility," 5th ed. Baltimore: Williams and Wilkins, 251-289, 1994.
6. Kadar N, Caldwell B, Romero R: A method of screening for ectopic pregnancy and its indications. Obstet Gynecol 58:162-165, 1981.
7. Kosasa TS: Measurement of hCG. In Goldstein DP, Berkowitz RS, (eds): "Gestational Trophoblastic Neoplasms: Clinical Principles of Diagnosis and Management," Vol. 14. Philadelphia: WB Saunders, 1982, p 64.
8. Crosignani PG: Correlation of human chorionic somatomammotropin (hCS) with fetal nutrition. In Josimovich JB (ed): "Lactogenic Hormones, Fetal Nutrition and Lactation." New York: John Wiley & Sons, 1973, pp. 203-220.
9. Wald NJ, Cuckle HS: Recent advances in screening for neural tube defects and Down's syndrome. Clin Obstet Gynaecol 1:649-676, 1987.
10. Wald NJ, Cuckle HS, Densem JW, et al.: Maternal serum screening for Down's syndrome in early pregnancy. BMJ 297:833-887, 1988.
11. Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, Sailer DN, Bowers GB: Prenatal screening for Down's syndrome with the use of maternal serum markers. N Engl J Med 327:588-593, 1992.
12. Phillips OP, Elias S, Shulman LP, Andersen RN, Morgan CD, Simpson JL: Maternal serum screening for fetal Down's syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study. Obstet Gynecol 80:353-358, 1992.
13. Burton BK, Prins GS, Verp MS: A prospective trial of prenatal screening for Down syndrome by means of maternal serum alphafetoprotein, human chorionic gonadotropin, and unconjugated estriol. Am J Obstet Gynecol 169:526-530, 1993.
14. Burton BK: Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein. Obstet Gynecol 72:709-713, 1988.
15. Davis RO, Goldberg RL, Boots L, Hoffman HJ, Copper R, Cutter GR, DuBard MB, Cliver SP, Smith RK: Elevated levels of midtrimester maternal serum alpha fetoprotein are associated with preterm delivery but not with fetal growth retardation. Am J Obstet Gynecol 167:596-601, 1992.
16. Santolaya J, Jessup J, Burd LI, Burton BK: Patients with low midtrimester maternal serum unconjugated estriol have an increased risk of pregnancy loss. J. Reprod Med 41:87-90, 1996.
17. Danzer H, Braunstein GD, Rasor J, et al.: Maternal serum human chorionic gonadotropin concentrations and fetal sex prediction. Fertil Steril 34:336-340, 1980.
18. Jameson JL, Hollenberg AN: Regulation of chorionic gonadotropin gene expression. Endocr Rev 14:203-212, 1993.
19. Fiddes JC, Goodman HM: The gene encoding the common alpha subunit of the four human glycoprotein hormones. J Mol Appl Genet 1:3-18, 1981.
20. Hussa RO: "The Clinical Marker hCG." New York: Praeger, 1987.
21. Suganuma N, Asada y, Furui K, et al.: Screening of the mutations in luteinizing hormone beta-subunit in patients with menstrual disorders. Fertil Steril 63:989-995, 1995.
22. Jones WR, Judd SF, Ing RMY, et al.: Phase I clinical trial of a World Health Organization birth control vaccine. Lancet 1:1295-1298, 1988.